---
schema_version: "secwatch.filing_event.v1"
accession: "0001210708-24-000052"
form_type: "8-K"
ticker: "STRR"
cik: "0001210708"
company_name: "Star Equity Holdings, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:42:35.012752+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Hudson Global extends NOL poison pill through October 2027, subject to stockholder approval

## Summary
- Second Amendment to Rights Agreement extends term to October 15, 2027.
- Stockholder approval required at 2024 annual meeting; without approval, amendment expires.
- Rights trigger at 4.99% beneficial ownership to deter ownership changes under Section 382.
- Any person or group exceeding 4.99% threshold has its rights voided and non-exercisable.
- Plan aims to preserve Hudson's substantial net operating loss carryforwards and related tax benefits.

## SEC filing metadata
- accession: 0001210708-24-000052
- form_type: 8-K
- ticker: STRR
- cik: 0001210708
- company_name: Star Equity Holdings, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1210708/000121070824000052/0001210708-24-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1210708/000121070824000052/hson-20240618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001210708-24-000052
- JSON: https://secwatch.observer/filing/0001210708-24-000052.json
- Plain text: https://secwatch.observer/filing/0001210708-24-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.